文献速递临床微生物分子诊断

2025年人类临床标本来源细菌新分类群及分类学修订综述

Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025.
PubMed 文献 · J Clin Microbiol · 2026-09-04

本综述汇总2025年从人类原发临床材料中分离的原核生物新分类群及现有分类学修订建议。超70个新专性厌氧分类群多源自微生物组研究,临床意义有限。

要点

  • 普罗威登斯菌属和肠杆菌属部分新分类群携带碳青霉烯类/高级别头孢菌素耐药基因型。
  • 超70个新专性厌氧分类群多来自微生物组研究,临床意义有限。

核心结论

  • 2025年人类临床标本来源细菌新分类群主要集中在链球菌属和肠杆菌目,部分新种携带多重耐药决定簇。

研究设计与样本

  • 本综述汇总2025年日历年内从人类原发临床材料中分离的原核生物新分类群及现有分类学修订建议。

主要发现

  • 全基因组测序和系统发育研究建议将5个种级链球菌分类群归为 Streptococcus mitis,另1个归为 Streptococcus oralis subsp. dentisani。
  • Stenotrophomonas muris sp. nov. 和 Terrisporobacter muris sp. nov. 在人类感染中的临床意义已由原始文献证实。
  • 超70个新专性厌氧分类群多源自微生物组研究,临床意义有限;4个新专性厌氧革兰阴性分类群在帕金森病患者中丰度高于非患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review summarizes novel taxon designations ascribed to prokaryotes derived from human primary clinical material during calendar year 2025, as well as proposed revisions to existing taxonomy. Major activity took place in the Streptococcus genus, as more than one dozen novel species were validly and effectively published, with two of these later classified as synonyms of Streptococcus thalassemiae. Moreover, whole genome sequencing and phylogenetic investigation of Streptococcus mitis group organisms resulted in a proposal to designate five species-level Streptococcus spp. taxa as Streptococcus mitis and an additional taxon as Streptococcus oralis subsp. dentisani. More than one dozen taxa were newly included in order Enterobacterales in 2025. Select novel taxa within genera Providencia and Enterobacter commonly possessed genotypes that conferred resistance to carbapenem and/or higher-generation cephem agents. Stenotrophomonas muris sp. nov. and Terrisporobacter muris sp. nov., initially characterized in gnotobiotic murine systems within the past 4 years, had clinical significance in human infection that was demonstrated in primary literature. The vast majority of the more than 70 novel obligate anaerobic taxa were derived from microbiome studies and had little ascribed clinical significance. Four novel obligate anaerobic Gram-negative taxa were shown to be of greater abundance in persons with Parkinson's disease than in those without. Updates to taxa previously published in the Journal of Clinical Microbiology compendia reveal that several could serve as reservoirs for multiple antimicrobial resistance determinants. One example is the non-glucose fermentative Gram-negative bacillus Pseudomonas juntendi.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Carella A, Carroll KC, Munson E, et al. Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025. J Clin Microbiol. 2026. PMID: 42695691. doi:10.1128/jcm.00973-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。